IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
Ontology highlight
ABSTRACT: The persistence of latent HIV reservoirs allows for viral rebound upon antiretroviral therapy interruption, hindering effective HIV-1 cure. Emerging evidence suggests that modulation of innate immune stimulation could impact viral latency and contribute to the clearing of HIV reservoir. Here, the latency reactivation capacity of a subclass of selective JAK2 inhibitors was characterized as a potential novel therapeutic strategy for HIV-1 cure. Notably, JAK2 inhibitors reversed HIV-1 latency in non-clonal lymphoid and myeloid in vitro models of HIV-1 latency and also ex vivo in CD4+ T cells from ART+ PWH, albeit its function was not dependent on JAK2 expression. Immunophenotypic characterization and whole transcriptomic profiling supported reactivation data, showing common gene
SUBMITTER: Ezeonwumelu IJ
PROVIDER: S-EPMC9484258 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA